Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.17480966 |
2 | positive thymic T cell selection (GO:0045059) | 5.60569739 |
3 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.55136870 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.39496449 |
5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.39496449 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.31782226 |
7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.19270162 |
8 | negative regulation of cell killing (GO:0031342) | 5.19270162 |
9 | negative thymic T cell selection (GO:0045060) | 4.99973822 |
10 | thymic T cell selection (GO:0045061) | 4.95429708 |
11 | negative T cell selection (GO:0043383) | 4.92127030 |
12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.90292551 |
13 | positive T cell selection (GO:0043368) | 4.64707912 |
14 | T cell selection (GO:0045058) | 4.47555613 |
15 | positive regulation of histone deacetylation (GO:0031065) | 4.25623492 |
16 | mannose metabolic process (GO:0006013) | 4.23575239 |
17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.22579079 |
18 | response to interleukin-15 (GO:0070672) | 4.14875892 |
19 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.06879093 |
20 | glycosphingolipid catabolic process (GO:0046479) | 3.77632828 |
21 | B cell receptor signaling pathway (GO:0050853) | 3.71194591 |
22 | natural killer cell differentiation (GO:0001779) | 3.63303548 |
23 | detection of other organism (GO:0098543) | 3.51321324 |
24 | complement activation, alternative pathway (GO:0006957) | 3.49789730 |
25 | response to peptidoglycan (GO:0032494) | 3.46491815 |
26 | interferon-gamma production (GO:0032609) | 3.43647007 |
27 | glycolipid catabolic process (GO:0019377) | 3.42305562 |
28 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.37580108 |
29 | cellular response to interleukin-15 (GO:0071350) | 3.37495969 |
30 | detection of bacterium (GO:0016045) | 3.36891531 |
31 | regulation of leukocyte degranulation (GO:0043300) | 3.36481276 |
32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34577971 |
33 | regulation of T cell tolerance induction (GO:0002664) | 3.32247192 |
34 | T cell receptor signaling pathway (GO:0050852) | 3.27673731 |
35 | oligosaccharide catabolic process (GO:0009313) | 3.27496264 |
36 | T cell costimulation (GO:0031295) | 3.26967559 |
37 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.22634128 |
38 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.22313792 |
39 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.22078354 |
40 | positive regulation of B cell differentiation (GO:0045579) | 3.21173455 |
41 | regulation of B cell differentiation (GO:0045577) | 3.19683249 |
42 | T cell migration (GO:0072678) | 3.19411751 |
43 | lymphocyte costimulation (GO:0031294) | 3.18817083 |
44 | protein localization to endosome (GO:0036010) | 3.17390017 |
45 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.16966072 |
46 | phospholipid efflux (GO:0033700) | 3.15114739 |
47 | urea cycle (GO:0000050) | 3.14118455 |
48 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.10248562 |
49 | response to muramyl dipeptide (GO:0032495) | 3.09329466 |
50 | urea metabolic process (GO:0019627) | 3.07370581 |
51 | detection of external biotic stimulus (GO:0098581) | 3.07334630 |
52 | response to thyroid hormone (GO:0097066) | 3.03809644 |
53 | positive regulation of protein deacetylation (GO:0090312) | 3.02641279 |
54 | macrophage activation involved in immune response (GO:0002281) | 3.01341248 |
55 | NIK/NF-kappaB signaling (GO:0038061) | 3.00021311 |
56 | regulation of mast cell degranulation (GO:0043304) | 2.99952426 |
57 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.97110196 |
58 | neutrophil activation involved in immune response (GO:0002283) | 2.93539473 |
59 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.89895737 |
60 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.89895737 |
61 | positive regulation by symbiont of host defense response (GO:0052509) | 2.89247393 |
62 | modulation by symbiont of host defense response (GO:0052031) | 2.89247393 |
63 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.89247393 |
64 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.89247393 |
65 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.89247393 |
66 | modulation by symbiont of host immune response (GO:0052553) | 2.89247393 |
67 | ceramide catabolic process (GO:0046514) | 2.89160827 |
68 | pinocytosis (GO:0006907) | 2.88608231 |
69 | detection of molecule of bacterial origin (GO:0032490) | 2.82816623 |
70 | negative regulation of phagocytosis (GO:0050765) | 2.82240144 |
71 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.80722852 |
72 | regulation of regulated secretory pathway (GO:1903305) | 2.79774495 |
73 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.79140384 |
74 | positive regulation of tolerance induction (GO:0002645) | 2.78385570 |
75 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.77155897 |
76 | nitrogen cycle metabolic process (GO:0071941) | 2.77007287 |
77 | T cell homeostasis (GO:0043029) | 2.76497355 |
78 | barbed-end actin filament capping (GO:0051016) | 2.73838640 |
79 | tolerance induction (GO:0002507) | 2.72672454 |
80 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.71965570 |
81 | detection of biotic stimulus (GO:0009595) | 2.71616346 |
82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.69904763 |
83 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.68905852 |
84 | hepatocyte apoptotic process (GO:0097284) | 2.68147580 |
85 | positive regulation of leukocyte degranulation (GO:0043302) | 2.66498123 |
86 | negative regulation of T cell mediated immunity (GO:0002710) | 2.64890382 |
87 | leukocyte cell-cell adhesion (GO:0007159) | 2.64557369 |
88 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.63925098 |
89 | germinal center formation (GO:0002467) | 2.63174060 |
90 | negative regulation of granulocyte differentiation (GO:0030853) | 2.62229039 |
91 | regulation of cholesterol esterification (GO:0010872) | 2.62018517 |
92 | response to laminar fluid shear stress (GO:0034616) | 2.60278031 |
93 | cortical actin cytoskeleton organization (GO:0030866) | 2.59703994 |
94 | Peyers patch development (GO:0048541) | 2.59444097 |
95 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.59444097 |
96 | activation of JUN kinase activity (GO:0007257) | 2.59359161 |
97 | megakaryocyte development (GO:0035855) | 2.59259877 |
98 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.58424029 |
99 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.57391870 |
100 | regulation of cholesterol storage (GO:0010885) | 2.56969560 |
101 | lymphocyte homeostasis (GO:0002260) | 2.56861869 |
102 | negative regulation of myotube differentiation (GO:0010832) | 2.56814212 |
103 | angiotensin maturation (GO:0002003) | 2.56713012 |
104 | leukocyte aggregation (GO:0070486) | 2.55130016 |
105 | negative regulation of interleukin-12 production (GO:0032695) | 2.54380201 |
106 | positive regulation of phagocytosis (GO:0050766) | 2.53868364 |
107 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.53654915 |
108 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.53622284 |
109 | natural killer cell activation (GO:0030101) | 2.53139369 |
110 | peptide catabolic process (GO:0043171) | 2.52439437 |
111 | positive regulation of isotype switching (GO:0045830) | 2.51613117 |
112 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.51133509 |
113 | positive regulation of cholesterol efflux (GO:0010875) | 2.48920444 |
114 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.48461481 |
115 | positive regulation of Rap GTPase activity (GO:0032854) | 2.47568224 |
116 | germ cell migration (GO:0008354) | 2.47466501 |
117 | positive regulation of interleukin-2 production (GO:0032743) | 2.46545072 |
118 | regulation of superoxide anion generation (GO:0032928) | 2.44757720 |
119 | heterotypic cell-cell adhesion (GO:0034113) | 2.44581053 |
120 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.43507398 |
121 | cellular extravasation (GO:0045123) | 2.43301637 |
122 | peptidyl-lysine dimethylation (GO:0018027) | 2.42948650 |
123 | regulation of response to interferon-gamma (GO:0060330) | 2.42089540 |
124 | serine transport (GO:0032329) | 2.41776223 |
125 | glial cell proliferation (GO:0014009) | 2.41150017 |
126 | regulation of macrophage chemotaxis (GO:0010758) | 2.40781622 |
127 | amino sugar catabolic process (GO:0046348) | 2.40137245 |
128 | growth hormone receptor signaling pathway (GO:0060396) | 2.39329480 |
129 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.37649898 |
130 | negative regulation of cell size (GO:0045792) | 2.37091662 |
131 | regulation of early endosome to late endosome transport (GO:2000641) | 2.37068476 |
132 | sodium ion export (GO:0071436) | 2.36832640 |
133 | regulation of cholesterol homeostasis (GO:2000188) | 2.36762296 |
134 | regulation of phagocytosis (GO:0050764) | 2.36433111 |
135 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.36116735 |
136 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.36116735 |
137 | regulation of regulatory T cell differentiation (GO:0045589) | 2.35622212 |
138 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.34671193 |
139 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.34037960 |
140 | positive regulation of mast cell degranulation (GO:0043306) | 2.34037960 |
141 | cellular response to zinc ion (GO:0071294) | 2.33349226 |
142 | negative regulation of sterol transport (GO:0032372) | 2.32633707 |
143 | negative regulation of cholesterol transport (GO:0032375) | 2.32633707 |
144 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.32369139 |
145 | complement activation (GO:0006956) | 2.31389689 |
146 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.31133263 |
147 | positive regulation of regulated secretory pathway (GO:1903307) | 2.30783203 |
148 | regulation of histone deacetylation (GO:0031063) | 2.29521806 |
149 | myeloid dendritic cell activation (GO:0001773) | 2.29149015 |
150 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.29044387 |
151 | positive regulation of lamellipodium assembly (GO:0010592) | 2.28711197 |
152 | negative regulation of histone methylation (GO:0031061) | 2.28270574 |
153 | B cell homeostasis (GO:0001782) | 2.28011880 |
154 | epoxygenase P450 pathway (GO:0019373) | 2.27725120 |
155 | regulation of tolerance induction (GO:0002643) | 2.27586632 |
156 | leukocyte tethering or rolling (GO:0050901) | 2.27344789 |
157 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.26719645 |
158 | establishment of endothelial barrier (GO:0061028) | 2.26425856 |
159 | regulation of ARF protein signal transduction (GO:0032012) | 2.25802825 |
160 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.25550169 |
161 | regulation of ARF GTPase activity (GO:0032312) | 2.24982502 |
162 | adherens junction assembly (GO:0034333) | 2.24461709 |
163 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.23433902 |
164 | regulation of monocyte differentiation (GO:0045655) | 2.23380747 |
165 | myeloid dendritic cell differentiation (GO:0043011) | 2.22335726 |
166 | cell-substrate junction assembly (GO:0007044) | 2.22137357 |
167 | positive regulation of lipid catabolic process (GO:0050996) | 2.22089151 |
168 | positive regulation of receptor recycling (GO:0001921) | 2.22084206 |
169 | stress fiber assembly (GO:0043149) | 2.21732791 |
170 | low-density lipoprotein particle remodeling (GO:0034374) | 2.21593244 |
171 | embryonic hemopoiesis (GO:0035162) | 2.21479966 |
172 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.21069382 |
173 | glucose 6-phosphate metabolic process (GO:0051156) | 2.20644167 |
174 | N-acetylneuraminate metabolic process (GO:0006054) | 2.20512186 |
175 | T cell proliferation (GO:0042098) | 2.20350601 |
176 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.19832053 |
177 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.19832053 |
178 | apoptotic process involved in morphogenesis (GO:0060561) | 2.19808392 |
179 | immunoglobulin mediated immune response (GO:0016064) | 2.19737973 |
180 | positive regulation of mast cell activation (GO:0033005) | 2.19376763 |
181 | protein-lipid complex assembly (GO:0065005) | 2.18422814 |
182 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.18290797 |
183 | regulation of apoptotic cell clearance (GO:2000425) | 2.18216054 |
184 | plasma lipoprotein particle assembly (GO:0034377) | 2.17541049 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.48612221 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.47778991 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 4.44647362 |
4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.84206754 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.33540890 |
6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.11992506 |
7 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.93553140 |
8 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.90235604 |
9 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.84586927 |
10 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.68513600 |
11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.67749189 |
12 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.64267852 |
13 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.64101188 |
14 | MAF_26560356_Chip-Seq_TH1_Human | 2.63056323 |
15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.52697518 |
16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.42773523 |
17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.33388721 |
18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.23036792 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22423267 |
20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.22335162 |
21 | MYB_26560356_Chip-Seq_TH2_Human | 2.22187351 |
22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.22063158 |
23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.12266469 |
24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.11283461 |
25 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.08910402 |
26 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.06850977 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05697831 |
28 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 2.04501343 |
29 | MYB_26560356_Chip-Seq_TH1_Human | 1.93979568 |
30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.91905945 |
31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81794761 |
32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79523648 |
33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.76951935 |
34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.76410611 |
35 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.75385823 |
36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72617860 |
37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.72560864 |
38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.72187181 |
39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.70900757 |
40 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64912500 |
41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.63935383 |
42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63221669 |
43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.62102939 |
44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59882642 |
45 | MAF_26560356_Chip-Seq_TH2_Human | 1.59640901 |
46 | KDM2B_26808549_Chip-Seq_K562_Human | 1.58583195 |
47 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.58262893 |
48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57974854 |
49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55906454 |
50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53896877 |
51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49114852 |
52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49104466 |
53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48649979 |
54 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.47278793 |
55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46074280 |
56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43137386 |
57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41611055 |
58 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.41418913 |
59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40528560 |
60 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.40399777 |
61 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.40189061 |
62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39898001 |
63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39182845 |
64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.38242110 |
65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37218380 |
66 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.36760699 |
67 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.35192713 |
68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33906115 |
69 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33841334 |
70 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32538818 |
71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32317058 |
72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.31904609 |
73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31562681 |
74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.30739657 |
75 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30022786 |
76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.27561326 |
77 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26988152 |
78 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24839015 |
79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24304265 |
80 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24279607 |
81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22818942 |
82 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.22044652 |
83 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21424105 |
84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20297999 |
85 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19161068 |
86 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18330725 |
87 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.18322447 |
88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.17007997 |
89 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16283792 |
90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15997103 |
91 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15112168 |
92 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15112168 |
93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13968443 |
94 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13607193 |
95 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12639339 |
96 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12348713 |
97 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11144819 |
98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10854843 |
99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10418239 |
100 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.10157019 |
101 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09110368 |
102 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08975124 |
103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08217515 |
104 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07897042 |
105 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06001894 |
106 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05890187 |
107 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05756775 |
108 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.05510722 |
109 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04684155 |
110 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.04088059 |
111 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03234609 |
112 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02124594 |
113 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01860882 |
114 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.01474557 |
115 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00677741 |
116 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00111808 |
117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96556337 |
118 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95855828 |
119 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95261342 |
120 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94973386 |
121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93900864 |
122 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.93413666 |
123 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92484880 |
124 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90735076 |
125 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90481427 |
126 | P68_20966046_ChIP-Seq_HELA_Human | 0.90063067 |
127 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88539374 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 4.39401634 |
2 | MP0003763_abnormal_thymus_physiology | 3.37757788 |
3 | MP0000685_abnormal_immune_system | 3.34924129 |
4 | MP0003300_gastrointestinal_ulcer | 3.33286454 |
5 | MP0002139_abnormal_hepatobiliary_system | 3.27946202 |
6 | MP0009840_abnormal_foam_cell | 3.16913304 |
7 | MP0003172_abnormal_lysosome_physiology | 3.15115316 |
8 | MP0003191_abnormal_cellular_cholesterol | 3.03752694 |
9 | MP0003303_peritoneal_inflammation | 2.87261824 |
10 | MP0003705_abnormal_hypodermis_morpholog | 2.63346527 |
11 | MP0001873_stomach_inflammation | 2.61980715 |
12 | MP0002396_abnormal_hematopoietic_system | 2.56909666 |
13 | MP0001800_abnormal_humoral_immune | 2.52645394 |
14 | MP0010352_gastrointestinal_tract_polyps | 2.51988168 |
15 | MP0001835_abnormal_antigen_presentation | 2.43209058 |
16 | MP0005451_abnormal_body_composition | 2.40327547 |
17 | MP0002166_altered_tumor_susceptibility | 2.38509359 |
18 | MP0004510_myositis | 2.37363354 |
19 | MP0005387_immune_system_phenotype | 2.35504745 |
20 | MP0001790_abnormal_immune_system | 2.35504745 |
21 | MP0008961_abnormal_basal_metabolism | 2.30610082 |
22 | MP0000604_amyloidosis | 2.27860512 |
23 | MP0005671_abnormal_response_to | 2.25248399 |
24 | MP0002398_abnormal_bone_marrow | 2.21847248 |
25 | MP0010234_abnormal_vibrissa_follicle | 2.10490285 |
26 | MP0004808_abnormal_hematopoietic_stem | 2.07925769 |
27 | MP0005360_urolithiasis | 2.06586379 |
28 | MP0000703_abnormal_thymus_morphology | 2.05011337 |
29 | MP0002420_abnormal_adaptive_immunity | 2.04113069 |
30 | MP0005409_darkened_coat_color | 2.03715369 |
31 | MP0005076_abnormal_cell_differentiation | 2.01942527 |
32 | MP0001819_abnormal_immune_cell | 2.01048015 |
33 | MP0002452_abnormal_antigen_presenting | 2.00216730 |
34 | MP0003329_amyloid_beta_deposits | 1.98437890 |
35 | MP0003866_abnormal_defecation | 1.96667159 |
36 | MP0004947_skin_inflammation | 1.89550208 |
37 | MP0009278_abnormal_bone_marrow | 1.88674582 |
38 | MP0005365_abnormal_bile_salt | 1.87265079 |
39 | MP0002006_tumorigenesis | 1.80951547 |
40 | MP0002723_abnormal_immune_serum | 1.80650102 |
41 | MP0000716_abnormal_immune_system | 1.79708654 |
42 | MP0003690_abnormal_glial_cell | 1.79205360 |
43 | MP0008260_abnormal_autophagy | 1.79019665 |
44 | MP0006054_spinal_hemorrhage | 1.76805064 |
45 | MP0005000_abnormal_immune_tolerance | 1.76450368 |
46 | MP0002722_abnormal_immune_system | 1.75980260 |
47 | MP0010155_abnormal_intestine_physiology | 1.75585051 |
48 | MP0003724_increased_susceptibility_to | 1.64636827 |
49 | MP0004185_abnormal_adipocyte_glucose | 1.63306500 |
50 | MP0000689_abnormal_spleen_morphology | 1.61008944 |
51 | MP0003566_abnormal_cell_adhesion | 1.58624936 |
52 | MP0002254_reproductive_system_inflammat | 1.54805921 |
53 | MP0003045_fibrosis | 1.51212185 |
54 | MP0003075_altered_response_to | 1.49118277 |
55 | MP0003279_aneurysm | 1.48984101 |
56 | MP0002429_abnormal_blood_cell | 1.48336900 |
57 | MP0002405_respiratory_system_inflammati | 1.45132046 |
58 | MP0003091_abnormal_cell_migration | 1.44503635 |
59 | MP0003436_decreased_susceptibility_to | 1.43221773 |
60 | MP0001348_abnormal_lacrimal_gland | 1.43212947 |
61 | MP0005464_abnormal_platelet_physiology | 1.38508465 |
62 | MP0005025_abnormal_response_to | 1.31951512 |
63 | MP0005397_hematopoietic_system_phenotyp | 1.31939251 |
64 | MP0001545_abnormal_hematopoietic_system | 1.31939251 |
65 | MP0004381_abnormal_hair_follicle | 1.29878215 |
66 | MP0002877_abnormal_melanocyte_morpholog | 1.28869952 |
67 | MP0009333_abnormal_splenocyte_physiolog | 1.28836162 |
68 | MP0004264_abnormal_extraembryonic_tissu | 1.28665777 |
69 | MP0000733_abnormal_muscle_development | 1.24921380 |
70 | MP0001853_heart_inflammation | 1.22834389 |
71 | MP0004130_abnormal_muscle_cell | 1.21629979 |
72 | MP0000490_abnormal_crypts_of | 1.19099832 |
73 | MP0000465_gastrointestinal_hemorrhage | 1.16710552 |
74 | MP0005085_abnormal_gallbladder_physiolo | 1.16593921 |
75 | MP0005166_decreased_susceptibility_to | 1.15291598 |
76 | MP0004084_abnormal_cardiac_muscle | 1.12658155 |
77 | MP0000858_altered_metastatic_potential | 1.12204546 |
78 | MP0000343_altered_response_to | 1.10365612 |
79 | MP0002933_joint_inflammation | 1.09801947 |
80 | MP0005666_abnormal_adipose_tissue | 1.08022923 |
81 | MP0010630_abnormal_cardiac_muscle | 1.06964254 |
82 | MP0002971_abnormal_brown_adipose | 1.06512890 |
83 | MP0008469_abnormal_protein_level | 1.05336842 |
84 | MP0004858_abnormal_nervous_system | 1.03946863 |
85 | MP0000751_myopathy | 1.03454455 |
86 | MP0005375_adipose_tissue_phenotype | 1.00829575 |
87 | MP0003453_abnormal_keratinocyte_physiol | 1.00623871 |
88 | MP0005670_abnormal_white_adipose | 0.99850636 |
89 | MP0003448_altered_tumor_morphology | 0.99281324 |
90 | MP0010329_abnormal_lipoprotein_level | 0.98929512 |
91 | MP0002138_abnormal_hepatobiliary_system | 0.97191306 |
92 | MP0000569_abnormal_digit_pigmentation | 0.96270399 |
93 | MP0004087_abnormal_muscle_fiber | 0.96000473 |
94 | MP0001845_abnormal_inflammatory_respons | 0.95990463 |
95 | MP0005623_abnormal_meninges_morphology | 0.95799430 |
96 | MP0000609_abnormal_liver_physiology | 0.94213377 |
97 | MP0002419_abnormal_innate_immunity | 0.94146058 |
98 | MP0004782_abnormal_surfactant_physiolog | 0.93782140 |
99 | MP0001666_abnormal_nutrient_absorption | 0.92583190 |
100 | MP0005023_abnormal_wound_healing | 0.92009279 |
101 | MP0003879_abnormal_hair_cell | 0.89791468 |
102 | MP0000920_abnormal_myelination | 0.89127316 |
103 | MP0005310_abnormal_salivary_gland | 0.88588056 |
104 | MP0008770_decreased_survivor_rate | 0.88292338 |
105 | MP0001851_eye_inflammation | 0.87780767 |
106 | MP0000015_abnormal_ear_pigmentation | 0.86830562 |
107 | MP0009115_abnormal_fat_cell | 0.86025115 |
108 | MP0000747_muscle_weakness | 0.84647413 |
109 | MP0009785_altered_susceptibility_to | 0.83546925 |
110 | MP0002118_abnormal_lipid_homeostasis | 0.83238554 |
111 | MP0000003_abnormal_adipose_tissue | 0.82997961 |
112 | MP0002019_abnormal_tumor_incidence | 0.82955064 |
113 | MP0003634_abnormal_glial_cell | 0.82575077 |
114 | MP0006082_CNS_inflammation | 0.81579920 |
115 | MP0002089_abnormal_postnatal_growth/wei | 0.79682452 |
116 | MP0003828_pulmonary_edema | 0.78138617 |
117 | MP0010307_abnormal_tumor_latency | 0.77768217 |
118 | MP0001958_emphysema | 0.77195509 |
119 | MP0001784_abnormal_fluid_regulation | 0.75715783 |
120 | MP0005501_abnormal_skin_physiology | 0.73734040 |
121 | MP0004019_abnormal_vitamin_homeostasis | 0.73423782 |
122 | MP0002925_abnormal_cardiovascular_devel | 0.72893757 |
123 | MP0000477_abnormal_intestine_morphology | 0.72564049 |
124 | MP0005381_digestive/alimentary_phenotyp | 0.72018062 |
125 | MP0008569_lethality_at_weaning | 0.71689137 |
126 | MP0009764_decreased_sensitivity_to | 0.71619933 |
127 | MP0003183_abnormal_peptide_metabolism | 0.71013633 |
128 | MP0002148_abnormal_hypersensitivity_rea | 0.69908053 |
129 | MP0001663_abnormal_digestive_system | 0.69681949 |
130 | MP0004859_abnormal_synaptic_plasticity | 0.69046352 |
131 | MP0002796_impaired_skin_barrier | 0.67924815 |
132 | MP0001849_ear_inflammation | 0.67509213 |
133 | MP0002998_abnormal_bone_remodeling | 0.66835391 |
134 | MP0002128_abnormal_blood_circulation | 0.62148685 |
135 | MP0001533_abnormal_skeleton_physiology | 0.62116495 |
136 | MP0001216_abnormal_epidermal_layer | 0.61598444 |
137 | MP0002009_preneoplasia | 0.60773669 |
138 | MP0000266_abnormal_heart_morphology | 0.60061059 |
139 | MP0001544_abnormal_cardiovascular_syste | 0.58348330 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.36836290 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.36836290 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.36836290 |
4 | Systemic lupus erythematosus (HP:0002725) | 4.36771791 |
5 | Increased cerebral lipofuscin (HP:0011813) | 4.15013262 |
6 | Dysostosis multiplex (HP:0000943) | 3.66832043 |
7 | Complement deficiency (HP:0004431) | 3.62820593 |
8 | Verrucae (HP:0200043) | 3.57969907 |
9 | Papilloma (HP:0012740) | 3.57969907 |
10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.47196808 |
11 | Agammaglobulinemia (HP:0004432) | 3.46567658 |
12 | Vacuolated lymphocytes (HP:0001922) | 3.45280929 |
13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.43107670 |
14 | Hyperacusis (HP:0010780) | 3.38422949 |
15 | Recurrent bronchitis (HP:0002837) | 3.36336042 |
16 | Abnormality of the fingertips (HP:0001211) | 3.34963003 |
17 | Abnormality of complement system (HP:0005339) | 3.34246660 |
18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.33367356 |
19 | T lymphocytopenia (HP:0005403) | 3.31058690 |
20 | Abnormality of macrophages (HP:0004311) | 3.26320729 |
21 | Panhypogammaglobulinemia (HP:0003139) | 3.19155880 |
22 | Glomerulonephritis (HP:0000099) | 3.18208588 |
23 | Neurofibrillary tangles (HP:0002185) | 3.17031741 |
24 | Chronic otitis media (HP:0000389) | 3.16980833 |
25 | Recurrent abscess formation (HP:0002722) | 3.15594701 |
26 | Cellulitis (HP:0100658) | 3.15059218 |
27 | Nasal polyposis (HP:0100582) | 3.09336262 |
28 | Abnormality of T cell number (HP:0011839) | 3.07065056 |
29 | Inflammation of the large intestine (HP:0002037) | 3.06364873 |
30 | Gastrointestinal inflammation (HP:0004386) | 3.04299652 |
31 | Increased density of long bones (HP:0006392) | 3.00706788 |
32 | Recurrent viral infections (HP:0004429) | 3.00653295 |
33 | Recurrent bacterial skin infections (HP:0005406) | 2.98466427 |
34 | Deep venous thrombosis (HP:0002625) | 2.97039440 |
35 | Loss of speech (HP:0002371) | 2.96684887 |
36 | Colitis (HP:0002583) | 2.92843381 |
37 | Mucopolysacchariduria (HP:0008155) | 2.90994147 |
38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.90994147 |
39 | Vertebral arch anomaly (HP:0008438) | 2.88982145 |
40 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.84444912 |
41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.84444912 |
42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.84444912 |
43 | Aortic aneurysm (HP:0004942) | 2.82651192 |
44 | Cerebral aneurysm (HP:0004944) | 2.80361444 |
45 | Recurrent fungal infections (HP:0002841) | 2.76884631 |
46 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.72724984 |
47 | Abnormality of the nasal mucosa (HP:0000433) | 2.70791645 |
48 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.70603786 |
49 | Increased IgE level (HP:0003212) | 2.65276417 |
50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.62196638 |
51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.62196638 |
52 | Cerebral inclusion bodies (HP:0100314) | 2.58037086 |
53 | Macroorchidism (HP:0000053) | 2.56588512 |
54 | Gingivitis (HP:0000230) | 2.55536971 |
55 | Hemorrhage of the eye (HP:0011885) | 2.46965405 |
56 | Amyloidosis (HP:0011034) | 2.44687051 |
57 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.43504240 |
58 | Axonal loss (HP:0003447) | 2.41386095 |
59 | Mediastinal lymphadenopathy (HP:0100721) | 2.39376160 |
60 | Abnormality of T cells (HP:0002843) | 2.39220124 |
61 | Thrombocytosis (HP:0001894) | 2.35558541 |
62 | IgM deficiency (HP:0002850) | 2.33481938 |
63 | Thoracic kyphosis (HP:0002942) | 2.31261729 |
64 | Purpura (HP:0000979) | 2.31245036 |
65 | Frequent falls (HP:0002359) | 2.27293332 |
66 | Broad metatarsal (HP:0001783) | 2.26909414 |
67 | Malnutrition (HP:0004395) | 2.26868374 |
68 | Neuronal loss in central nervous system (HP:0002529) | 2.25803764 |
69 | Myocardial infarction (HP:0001658) | 2.21799242 |
70 | Viral hepatitis (HP:0006562) | 2.20233935 |
71 | Abnormality of oral frenula (HP:0000190) | 2.19742745 |
72 | Meningitis (HP:0001287) | 2.19301238 |
73 | Dilatation of the ascending aorta (HP:0005111) | 2.17000217 |
74 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16810784 |
75 | Obstructive lung disease (HP:0006536) | 2.16810784 |
76 | Hematochezia (HP:0002573) | 2.16798339 |
77 | Xanthomatosis (HP:0000991) | 2.16583949 |
78 | Asymmetric septal hypertrophy (HP:0001670) | 2.15972869 |
79 | Abnormal platelet volume (HP:0011876) | 2.15216763 |
80 | Disinhibition (HP:0000734) | 2.14440449 |
81 | Emphysema (HP:0002097) | 2.14041874 |
82 | Pustule (HP:0200039) | 2.13399778 |
83 | Abnormality of the thoracic spine (HP:0100711) | 2.12265343 |
84 | Mitral valve prolapse (HP:0001634) | 2.09520961 |
85 | Rectal prolapse (HP:0002035) | 2.08521203 |
86 | Short 4th metacarpal (HP:0010044) | 2.05759161 |
87 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.05759161 |
88 | Subacute progressive viral hepatitis (HP:0006572) | 2.05655324 |
89 | Polygenic inheritance (HP:0010982) | 1.99618147 |
90 | Orchitis (HP:0100796) | 1.99617714 |
91 | Bicuspid aortic valve (HP:0001647) | 1.98481095 |
92 | Chest pain (HP:0100749) | 1.97567743 |
93 | Shallow orbits (HP:0000586) | 1.97006599 |
94 | Apathy (HP:0000741) | 1.96715657 |
95 | Hemiplegia (HP:0002301) | 1.96516005 |
96 | Interstitial pulmonary disease (HP:0006530) | 1.95373099 |
97 | Flat acetabular roof (HP:0003180) | 1.95361703 |
98 | Distal lower limb amyotrophy (HP:0008944) | 1.95008183 |
99 | Thin bony cortex (HP:0002753) | 1.94400618 |
100 | Pointed chin (HP:0000307) | 1.94204485 |
101 | Mitral regurgitation (HP:0001653) | 1.94041245 |
102 | Dysmetric saccades (HP:0000641) | 1.93501882 |
103 | Joint hemorrhage (HP:0005261) | 1.92783533 |
104 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92694247 |
105 | Bone pain (HP:0002653) | 1.91936236 |
106 | Lower limb amyotrophy (HP:0007210) | 1.91394816 |
107 | Polycythemia (HP:0001901) | 1.91219632 |
108 | Nephritis (HP:0000123) | 1.91043864 |
109 | Diminished motivation (HP:0000745) | 1.90095173 |
110 | Recurrent skin infections (HP:0001581) | 1.89648080 |
111 | J-shaped sella turcica (HP:0002680) | 1.89432723 |
112 | Elfin facies (HP:0004428) | 1.88459289 |
113 | Peripheral demyelination (HP:0011096) | 1.87927219 |
114 | Basal cell carcinoma (HP:0002671) | 1.87819054 |
115 | Obstructive sleep apnea (HP:0002870) | 1.86549111 |
116 | Persistence of primary teeth (HP:0006335) | 1.86377316 |
117 | Insomnia (HP:0100785) | 1.85493986 |
118 | Increased serum ferritin (HP:0003281) | 1.85359708 |
119 | Increased mean platelet volume (HP:0011877) | 1.85149270 |
120 | Prolonged bleeding time (HP:0003010) | 1.84812475 |
121 | Ulnar bowing (HP:0003031) | 1.84357400 |
122 | Myositis (HP:0100614) | 1.82989449 |
123 | Pathologic fracture (HP:0002756) | 1.82937746 |
124 | Lymphopenia (HP:0001888) | 1.82844735 |
125 | Aneurysm (HP:0002617) | 1.82743714 |
126 | Thyroiditis (HP:0100646) | 1.80784823 |
127 | Difficulty running (HP:0009046) | 1.80529526 |
128 | Distal lower limb muscle weakness (HP:0009053) | 1.80160596 |
129 | Enlarged penis (HP:0000040) | 1.79277590 |
130 | Hypercortisolism (HP:0001578) | 1.78120278 |
131 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77320822 |
132 | Cardiomegaly (HP:0001640) | 1.76777508 |
133 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76349307 |
134 | Abnormality of the periventricular white matter (HP:0002518) | 1.76171166 |
135 | Spontaneous hematomas (HP:0007420) | 1.75983769 |
136 | Striae distensae (HP:0001065) | 1.75134617 |
137 | Mutism (HP:0002300) | 1.74961381 |
138 | Supranuclear gaze palsy (HP:0000605) | 1.74912662 |
139 | Protrusio acetabuli (HP:0003179) | 1.74819868 |
140 | Nuclear cataract (HP:0100018) | 1.74782568 |
141 | Gingival bleeding (HP:0000225) | 1.74727424 |
142 | Radial bowing (HP:0002986) | 1.74509005 |
143 | Abnormality of B cell number (HP:0010975) | 1.73781976 |
144 | B lymphocytopenia (HP:0010976) | 1.73781976 |
145 | Gastrointestinal stroma tumor (HP:0100723) | 1.73729260 |
146 | Epistaxis (HP:0000421) | 1.73500051 |
147 | Heterotopia (HP:0002282) | 1.73137243 |
148 | Upper motor neuron abnormality (HP:0002127) | 1.72869360 |
149 | Arterial thrombosis (HP:0004420) | 1.72488829 |
150 | Eczematoid dermatitis (HP:0000976) | 1.72067899 |
151 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71774632 |
152 | Papilledema (HP:0001085) | 1.71566819 |
153 | Chronic sinusitis (HP:0011109) | 1.70808631 |
154 | Onion bulb formation (HP:0003383) | 1.70021232 |
155 | Broad face (HP:0000283) | 1.68818189 |
156 | Hyporeflexia of lower limbs (HP:0002600) | 1.68370368 |
157 | Hepatosplenomegaly (HP:0001433) | 1.68336488 |
158 | Arterial tortuosity (HP:0005116) | 1.66783336 |
159 | Abdominal distention (HP:0003270) | 1.66193233 |
160 | Abnormality of the gastric mucosa (HP:0004295) | 1.65718135 |
161 | Syringomyelia (HP:0003396) | 1.65698856 |
162 | Spinal cord lesions (HP:0100561) | 1.65698856 |
163 | Bowel diverticulosis (HP:0005222) | 1.65422694 |
164 | Pulmonary embolism (HP:0002204) | 1.65032550 |
165 | Fatigue (HP:0012378) | 1.64792371 |
166 | Abnormality of T cell physiology (HP:0011840) | 1.64402261 |
167 | Vertebral compression fractures (HP:0002953) | 1.64348959 |
168 | Dementia (HP:0000726) | 1.64282310 |
169 | Abnormality of the lumbar spine (HP:0100712) | 1.63984246 |
170 | Visceral angiomatosis (HP:0100761) | 1.63482963 |
171 | Osteomyelitis (HP:0002754) | 1.62481263 |
172 | Bowed forearm bones (HP:0003956) | 1.62329372 |
173 | Bowing of the arm (HP:0006488) | 1.62329372 |
174 | Aortic dissection (HP:0002647) | 1.62248294 |
175 | Hypertriglyceridemia (HP:0002155) | 1.62112191 |
176 | Broad palm (HP:0001169) | 1.61636282 |
177 | Combined immunodeficiency (HP:0005387) | 1.61595650 |
178 | Aortic regurgitation (HP:0001659) | 1.61021723 |
179 | Ankle contracture (HP:0006466) | 1.60593047 |
180 | Narrow palate (HP:0000189) | 1.59878152 |
181 | Personality changes (HP:0000751) | 1.58703583 |
182 | Retrobulbar optic neuritis (HP:0100654) | 1.58685313 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PRPF4B | 4.43336831 |
2 | MAP3K10 | 4.37914630 |
3 | TRIB3 | 4.12391623 |
4 | MAP4K1 | 3.93817432 |
5 | EEF2K | 3.75293115 |
6 | PKN2 | 3.61260164 |
7 | RIPK4 | 2.60325548 |
8 | TTN | 2.45005487 |
9 | GRK6 | 2.22681299 |
10 | LRRK2 | 2.14417476 |
11 | STK10 | 2.13099153 |
12 | SIK2 | 1.95527828 |
13 | SMG1 | 1.83844772 |
14 | JAK3 | 1.82475874 |
15 | ICK | 1.80448191 |
16 | FGFR4 | 1.75017013 |
17 | ITK | 1.73237202 |
18 | IRAK3 | 1.73160696 |
19 | PTK6 | 1.72736157 |
20 | MAP3K7 | 1.66290921 |
21 | FGFR3 | 1.59914652 |
22 | TAOK1 | 1.49990198 |
23 | CDK12 | 1.45007819 |
24 | JAK1 | 1.44452266 |
25 | TAOK2 | 1.42642885 |
26 | TYK2 | 1.41297707 |
27 | MAP3K13 | 1.34455464 |
28 | RIPK1 | 1.33823977 |
29 | ZAP70 | 1.33263311 |
30 | MAP3K1 | 1.30208429 |
31 | SIK1 | 1.28673096 |
32 | ERN1 | 1.24317265 |
33 | MAP3K3 | 1.18158951 |
34 | HCK | 1.17596680 |
35 | PDPK1 | 1.16903294 |
36 | BTK | 1.13764056 |
37 | EPHB1 | 1.10508173 |
38 | PRKCH | 1.09733784 |
39 | MAP3K11 | 1.09694557 |
40 | PDGFRA | 1.07137350 |
41 | ALK | 1.06228056 |
42 | DMPK | 1.06105565 |
43 | MARK2 | 1.05027172 |
44 | MAP3K6 | 1.04561814 |
45 | TYRO3 | 1.03666974 |
46 | TXK | 1.02650250 |
47 | RET | 1.02211100 |
48 | SYK | 1.02090939 |
49 | TBK1 | 0.95410599 |
50 | MATK | 0.94952510 |
51 | MAP3K14 | 0.93307145 |
52 | IRAK4 | 0.90434741 |
53 | RPS6KA4 | 0.90430526 |
54 | HIPK2 | 0.88507758 |
55 | MAP3K2 | 0.87967487 |
56 | LCK | 0.86814676 |
57 | CSK | 0.86460610 |
58 | RPS6KC1 | 0.85580096 |
59 | RPS6KL1 | 0.85580096 |
60 | LMTK2 | 0.84585040 |
61 | STK11 | 0.83124721 |
62 | DDR2 | 0.82216512 |
63 | PRKD2 | 0.81465618 |
64 | SCYL2 | 0.80450867 |
65 | PDGFRB | 0.80410108 |
66 | BLK | 0.79449542 |
67 | JAK2 | 0.77885806 |
68 | CDK4 | 0.76055617 |
69 | RPS6KB2 | 0.75959594 |
70 | MARK3 | 0.75652064 |
71 | PRKD1 | 0.75265213 |
72 | TNK2 | 0.74699824 |
73 | CDK9 | 0.72834932 |
74 | MAPK7 | 0.72434037 |
75 | FGFR2 | 0.71532735 |
76 | TGFBR2 | 0.70967851 |
77 | CAMK1D | 0.70665969 |
78 | NME2 | 0.70596882 |
79 | MAP2K2 | 0.69970723 |
80 | FGR | 0.69843050 |
81 | PIM1 | 0.69771959 |
82 | IKBKE | 0.69297440 |
83 | STK24 | 0.68933461 |
84 | MAPK11 | 0.68452317 |
85 | NEK2 | 0.67547361 |
86 | MAP2K6 | 0.66623028 |
87 | CSF1R | 0.66128303 |
88 | CAMKK1 | 0.65834284 |
89 | NLK | 0.65720021 |
90 | CAMK1G | 0.65542968 |
91 | CDK6 | 0.63863224 |
92 | BMX | 0.63829042 |
93 | RPS6KA6 | 0.63304233 |
94 | IRAK2 | 0.63007889 |
95 | FLT3 | 0.62539816 |
96 | FES | 0.62267772 |
97 | PDK1 | 0.61919600 |
98 | CHUK | 0.61276449 |
99 | MAP3K8 | 0.60754860 |
100 | MTOR | 0.57967911 |
101 | PRKCQ | 0.55839780 |
102 | MAP2K3 | 0.55414933 |
103 | LYN | 0.54987040 |
104 | EPHA3 | 0.54751940 |
105 | MAPK4 | 0.52796852 |
106 | KIT | 0.52425876 |
107 | PRKG2 | 0.51345530 |
108 | CLK1 | 0.51257351 |
109 | IKBKB | 0.50330720 |
110 | DYRK1B | 0.49993724 |
111 | ILK | 0.48918968 |
112 | KSR2 | 0.47850649 |
113 | MAPK12 | 0.46699618 |
114 | PAK2 | 0.46360096 |
115 | CDC42BPA | 0.46007390 |
116 | SGK3 | 0.45444352 |
117 | MST1R | 0.45433324 |
118 | PRKAA2 | 0.44395853 |
119 | TEC | 0.44395410 |
120 | TESK2 | 0.44279147 |
121 | TGFBR1 | 0.43676105 |
122 | FGFR1 | 0.43017751 |
123 | PRKD3 | 0.42704091 |
124 | MAPKAPK3 | 0.41785759 |
125 | MELK | 0.41305361 |
126 | STK4 | 0.40632645 |
127 | MAP2K4 | 0.40435931 |
128 | YES1 | 0.38752651 |
129 | MAP3K9 | 0.38406431 |
130 | PTK2 | 0.38115183 |
131 | TRPM7 | 0.36997897 |
132 | CAMK4 | 0.36552424 |
133 | PAK6 | 0.35597757 |
134 | FYN | 0.35316106 |
135 | RPS6KA2 | 0.35240972 |
136 | RPS6KA1 | 0.34323824 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.13641836 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.05966816 |
3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.72083339 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.44228856 |
5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.38223684 |
6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.09730018 |
7 | Lysosome_Homo sapiens_hsa04142 | 1.92780674 |
8 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.92463500 |
9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.92311608 |
10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.86517549 |
11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.78638107 |
12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.74222278 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.67374659 |
14 | Prion diseases_Homo sapiens_hsa05020 | 1.65141094 |
15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61880926 |
16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.61361962 |
17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.59084500 |
18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53773389 |
19 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.48821497 |
20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.45187635 |
21 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.44127266 |
22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.43678816 |
23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.43486624 |
24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41006652 |
25 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.40168434 |
26 | Platelet activation_Homo sapiens_hsa04611 | 1.40091344 |
27 | Measles_Homo sapiens_hsa05162 | 1.36983604 |
28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.36463452 |
29 | Colorectal cancer_Homo sapiens_hsa05210 | 1.35366410 |
30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.33438500 |
31 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.30262459 |
32 | Leishmaniasis_Homo sapiens_hsa05140 | 1.28330820 |
33 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.26852295 |
34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24443414 |
35 | Endometrial cancer_Homo sapiens_hsa05213 | 1.19714646 |
36 | Pertussis_Homo sapiens_hsa05133 | 1.15347132 |
37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14679348 |
38 | Glioma_Homo sapiens_hsa05214 | 1.13421833 |
39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12960468 |
40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12620949 |
41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10838949 |
42 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.09575115 |
43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09372800 |
44 | Hepatitis B_Homo sapiens_hsa05161 | 1.08124779 |
45 | HTLV-I infection_Homo sapiens_hsa05166 | 1.07960530 |
46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07395785 |
47 | Focal adhesion_Homo sapiens_hsa04510 | 1.07128613 |
48 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.05879477 |
49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04316709 |
50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02849964 |
51 | Bile secretion_Homo sapiens_hsa04976 | 1.02434102 |
52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02285808 |
53 | Insulin resistance_Homo sapiens_hsa04931 | 1.01178221 |
54 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.01144885 |
55 | Apoptosis_Homo sapiens_hsa04210 | 1.00140875 |
56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99249916 |
57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98346769 |
58 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.97142073 |
59 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.96880068 |
60 | Shigellosis_Homo sapiens_hsa05131 | 0.96484652 |
61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96340460 |
62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96063606 |
63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93388681 |
64 | Phagosome_Homo sapiens_hsa04145 | 0.92853831 |
65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90896506 |
66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90741998 |
67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90114638 |
68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.88929509 |
69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88206106 |
70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88197488 |
71 | Adherens junction_Homo sapiens_hsa04520 | 0.87744654 |
72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.87459798 |
73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87140626 |
74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.86902129 |
75 | Asthma_Homo sapiens_hsa05310 | 0.86238830 |
76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86226234 |
77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83814064 |
78 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83670761 |
79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.82407023 |
80 | Hepatitis C_Homo sapiens_hsa05160 | 0.82372949 |
81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.82005463 |
82 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81336033 |
83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80518189 |
84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.79821067 |
85 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.79401475 |
86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79298225 |
87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78747356 |
88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78274463 |
89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.77312706 |
90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76638806 |
91 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.76598230 |
92 | Endocytosis_Homo sapiens_hsa04144 | 0.76422042 |
93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.76231536 |
94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.76017817 |
95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75352381 |
96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75180736 |
97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.74889225 |
98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.74275353 |
99 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.74087691 |
100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73948508 |
101 | Tuberculosis_Homo sapiens_hsa05152 | 0.73528873 |
102 | Lysine degradation_Homo sapiens_hsa00310 | 0.73272258 |
103 | Allograft rejection_Homo sapiens_hsa05330 | 0.72703931 |
104 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72652184 |
105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72578579 |
106 | Influenza A_Homo sapiens_hsa05164 | 0.72005138 |
107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70739050 |
108 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70257444 |
109 | Malaria_Homo sapiens_hsa05144 | 0.68856384 |
110 | Bladder cancer_Homo sapiens_hsa05219 | 0.68208109 |
111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66829323 |
112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66682884 |
113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66578300 |
114 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66107908 |
115 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65501816 |
116 | Amoebiasis_Homo sapiens_hsa05146 | 0.65459803 |
117 | Salmonella infection_Homo sapiens_hsa05132 | 0.64873565 |
118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64078778 |
119 | Pathways in cancer_Homo sapiens_hsa05200 | 0.62813128 |
120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62534946 |
121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62219355 |
122 | Prostate cancer_Homo sapiens_hsa05215 | 0.61943609 |
123 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61525413 |
124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60885064 |
125 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60879261 |
126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60610675 |
127 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60357405 |
128 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59960984 |
129 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55987601 |
130 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52928590 |
131 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52396310 |
132 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46305715 |
133 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45156283 |
134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44912724 |
135 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44148884 |